KK Shailaja urges Keralam Government to review new SMA drug distribution amid parents’ concerns
CPI(M) Central Committee member K.K. Shailaja has urged the Keralam government to urgently review its decision to introduce a new medicine for patients with Spinal Muscular Atrophy (SMA), citing concerns raised by parents over the proposed replacement of the medication their children are currently receiving.

Shailaja said parents had reported improvements in their children’s health while taking the medicine previously supplied by Roche. She cited the case of twins with SMA in Mattannur whose parents had contacted her after being informed that their medication would be changed.
According to the parents, the children, who had been bedridden, had begun making progress, including attempting to stand and walk. They expressed apprehension about switching to the new medicine after observing these improvements with the existing treatment.
Shailaja also raised concerns over allegations that patients had been supplied medicine from sample bottles intended for testing. She said the claim, if substantiated, would represent a serious issue requiring immediate investigation.
Questioning the decision to introduce the new medicine through an order issued in July, she sought clarity on its safety, quality, efficacy and possible side effects. She also questioned why the Health Minister had reportedly said she was unaware of the new medicine.
Emphasising that SMA is a genetic disorder that cannot currently be completely cured, Shailaja said medication can nevertheless improve patients’ health and quality of life.
She argued that lower prices should not be the sole criterion for selecting medicines, particularly when children’s lives are involved. The government must assess the medicines’ quality, safety and potential risks rather than rely solely on cost considerations, she said.
Shailaja called on the Health Department to intervene immediately, stressing that the Health Minister could not distance herself from the issue by leaving the decision entirely to officials.